Scanner DailyTickers — Tuesday, May 12, 2026

Micron surging +6.5% to new all-time high ($818.67) on HBM3E demand explosion for AI training clusters. The memory cycle has inflected — DRAM pricing power is returning as data center buildout accelerates globally. HBM3E is sold out through 2027 with NVIDIA, AMD, and cloud hyperscalers competing for allocation. Massive bullish unusual options activity across 30+ strikes confirms institutional smart money positioning aggressively long. Forward PE remains attractive relative to 50%+ revenue growth trajectory. This is the top conviction breakout of the session.

Corning exploding +10.9% to ATH ($208.92) on fiber optic demand surge for AI data center interconnects. Optical connectivity is emerging as the critical bottleneck for GPU cluster scaling — each 100K GPU cluster requires massive fiber infrastructure, and Corning is the dominant global supplier. The Gorilla Glass franchise provides consumer tech exposure while optical fiber captures enterprise AI buildout. This is a picks-and-shovels AI play that the market is just beginning to price.

Intel breaking to new ATH ($132.75) as the foundry transformation thesis gains institutional conviction. 18A process node is on track with early customer tape-outs validating the technology. CHIPS Act subsidies are flowing ($8.5B grant + $11B loan). Short interest declining as bears capitulate on the turnaround story. The market is repricing Intel from “legacy chipmaker” to “western foundry champion” — this re-rating has further to run.

Fortinet touching ATH ($115.48) as cybersecurity spending remains non-discretionary amid escalating threat landscape. The FortiAI-powered security operations center is driving ARPU expansion across the installed base. Platform consolidation strategy winning large enterprise deals vs point-solution competitors. Firewall refresh cycle providing multi-quarter revenue visibility. Billings growth re-accelerating after the 2024-2025 digestion period.

Eli Lilly momentum play above 50-DMA ($941.78) as the GLP-1 franchise continues its blockbuster trajectory. Mounjaro and Zepbound are generating unprecedented revenue growth in diabetes and obesity. The total addressable market for obesity treatment is expanding as insurance coverage broadens and international launches accelerate. Pipeline depth with orforglipron (oral GLP-1) represents the next major catalyst. Healthcare sector rotation into quality growth supports the momentum setup.

Nucor approaching ATH ($235.44) on converging infrastructure tailwinds: AI data center construction, reshoring of manufacturing, and federal infrastructure spending. As the lowest-cost US steelmaker with electric arc furnace technology, Nucor benefits from both volume and pricing. Section 232 tariff protection provides a pricing floor. Conservative balance sheet (lowest debt/equity in the steel sector) supports sustained capital returns. The materials sector is quietly benefiting from the same AI buildout driving semiconductors.

Novo Nordisk offers a pullback entry into the GLP-1 megatrend at a significant discount to peer LLY. FwdPE 13.7x vs LLY’s 55x+ creates a compelling relative value setup. Wegovy and Ozempic continue to deliver strong revenue growth with manufacturing capacity expansion underway in Denmark and North Carolina. CagriSema (next-gen amylin/GLP-1 combo) Phase 3 data expected soon — potential best-in-class weight loss efficacy. European healthcare champion with global commercial infrastructure.

TotalEnergies in momentum near ATH ($93.67) benefiting from supportive oil and LNG pricing. The integrated energy model — combining traditional hydrocarbons with a growing renewables portfolio — provides defensive characteristics with upside optionality. Attractive 4%+ dividend yield creates an income floor. EU energy security premium persists post-2022. Price +2.5% with 8% above 50-DMA confirming sustained uptrend. Weak DXY amplifies EUR-denominated earnings.

iShares South Korea ETF at ATH ($194.58) driven by Samsung and SK Hynix memory chip surge. Korea semiconductor exports at record levels as HBM demand creates a supercycle for Korean memory manufacturers. EWY provides diversified APAC exposure with 60%+ weight in technology (Samsung, SK Hynix, LG). The AI memory thesis plays out most directly through Korean chipmakers who control 70%+ of global HBM supply. Bullish unusual options activity confirms institutional flow.

iShares Semiconductor ETF at ATH ($533.74) capturing the broadest semiconductor rally since the AI cycle began. Unlike single-stock exposure, SOXX provides diversified access to NVDA, AMD, AVGO, MU, QCOM, INTC — all at or near all-time highs. The breakout above prior resistance confirms that the semiconductor rally is broadening from NVDA-only to sector-wide participation. This is the highest-conviction sector beta play for the AI infrastructure cycle — lower risk than any individual name with full sector upside capture.